News
News Medical on MSN15h
Cancer immunotherapies linked to increased risk of liver cholestasisA global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger cholestasis, a serious liver condition where bile flow stalls.
A global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger cholestasis, a serious liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback